Clinical Trials

Esophageal Cancer

Advanced or Metastatic

TORI GI-05: A Phase II study of Erlotinib (Tarceva) and modified FOLFOX 6 (5-Fluorocuracil, Leucovorin and Oxaliplatin) in previously untreated patients with unresectable or metastatic adenocarcinoma of the esophagus and gastric cardia. [UCLA]

For more information on VCHOS trials, please call Ruth Ann Begun at (805) 485-8709 ext 136 or email at rbegun@venturaoncology.com.   

For more information on  UCLA network trials, please call  Pamela Riach at (805) 485-8709 ext 129 or email at priach@mednet.ucla.edu.